{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:05:47Z","timestamp":1793279147346,"version":"4.5.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>There is limited and conflicting data available regarding the cardiovascular disease outcomes associated with inflammatory bowel disease (IBD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>We aim to perform a systematic review to evaluate the cardiovascular outcomes and mortality associated with IBD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic literature search has been performed on PubMed, Embase, Cochrane, and Scopus from inception till May 2022 without any language restrictions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 2,029,941 patients were included in the analysis from 16 studies. The mean age of the patients was 45.6 years. More females were found compared with males (57% vs 43%). The most common risk factors for cardiovascular disease (CVD) included smoking (24.19%) and alcohol (4.60%). The most common comorbidities includes hypertension (30%), diabetes mellitus (14.41%), dyslipidemia (18.42%), previous CVD (22%), and renal disease (10%). Among outcomes, all-cause mortality among IBD patients was 1.66%; ulcerative colitis (UC): 15.92%; and Crohn disease (CD): 0.30%. Myocardial Infarction (MI) among IBD patients were 1.47%, UC: 30.96%; and CD: 34.14%. CVD events among IBD patients were 1.95%. Heart failure events among IBD patients were 5.49%, stroke events among IBD patients were 0.95%, UC: 2.63%, and CD: 2.41%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>IBD patients are at higher risk for adverse cardiovascular outcomes, especially in women. Although there remains a lack of concrete treatment algorithms and assessment parameters that better characterize IBD risk factors, nutritional modifications and physical activity should be at the forefront of CVD prevention in IBD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032775","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:22:12Z","timestamp":1676046132000},"page":"e32775","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":39,"title":["Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review"],"prefix":"10.1097","volume":"102","author":[{"given":"Vikash","family":"Jaiswal","sequence":"first","affiliation":[{"name":"Larkin Community Hospital, South Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Beaumont Hospital, Royal Oak, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehak","family":"Dagar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Himalayan Institute of Medical Science, Dehradun, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swatika","family":"Butey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indira Gandhi Government Medical College, Nagpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Huang","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, University of Medicine and Health Science, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Ee","family":"Chia","sequence":"additional","affiliation":[{"name":"Department of Medicine, International Medical University, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Naz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evbayekha O.","family":"Endurance","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, St. Luke\u2019s Hospital, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishchita","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Medicine, B. P. Koirala Institute of Health Sciences, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srushti","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, GMERS Medical College, Gandhinagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipansha","family":"Maroo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Peng","family":"Ang","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Rutgers Health\/Community Medical Center, Toms River, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Hanif","sequence":"additional","affiliation":[{"name":"Suny Upstate Medical University, Syracuse, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dattatreya","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Raiganj Government Medical College and Hospital, Raiganj, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouina","family":"Sarfraz","sequence":"additional","affiliation":[{"name":"Research and Publication, Fatima Jinnah Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-3825","authenticated-orcid":false,"given":"Abhigan Babu","family":"Shrestha","sequence":"additional","affiliation":[{"name":"M Abdur Rahim Medical College, Dinajpur, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease.","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.110.951236","article-title":"Venous thromboembolism and atherothrombosis: an integrated approach.","volume":"121","author":"Piazza","year":"2010","journal-title":"Circulation"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.2010.143396","article-title":"The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study.","volume":"70","author":"Lindhardsen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study.","volume":"130","author":"Dregan","year":"2014","journal-title":"Circulation"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ajg.2011.53","article-title":"Venous thromboembolism in inflammatory bowel disease: an epidemiological review.","volume":"106","author":"Murthy","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ajg.2009.81","article-title":"Risk of arterial thrombotic events in inflammatory bowel disease.","volume":"104","author":"Ha","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2036.2005.02657.x","article-title":"Increased carotid intima-media thickness in patients with inflammatory bowel disease.","volume":"22","author":"Papa","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0003319709333869","article-title":"Is inflammatory bowel disease a risk factor for early atherosclerosis?.","volume":"61","author":"Dagli","year":"2010","journal-title":"Angiology"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/MIB.0b013e318280b19e","article-title":"Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn\u2019s disease, and ulcerative colitis patients.","volume":"19","author":"Plevy","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.1104911","article-title":"Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.","volume":"307","author":"Kobayashi","year":"2005","journal-title":"Science"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2003.12.028","article-title":"C-reactive protein and microalbuminuria are associated with atrial fibrillation.","volume":"98","author":"Asselbergs","year":"2005","journal-title":"Int J Cardiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00059-009-3318-2","article-title":"Biomarkers in inflammatory and noninflammatory cardiomyopathy.","volume":"34","author":"Noutsias","year":"2009","journal-title":"Herz"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/RHU.0b013e3181638173","article-title":"Relapsing polychondritis presenting with complete heart block.","volume":"14","author":"Hojaili","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"R15-20250504","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease.","volume":"166","author":"Crowson","year":"2013","journal-title":"Am Heart J"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.3748\/wjg.v23.i36.6628","article-title":"Glucocorticosteroid therapy in inflammatory bowel diseases: from clinical practice to molecular biology.","volume":"23","author":"Dubois-Camacho","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e005892","DOI":"10.1161\/JAHA.117.005892","article-title":"Inflammatory bowel disease and risk of ischemic heart disease: an updated meta-analysis of cohort studies.","volume":"6","author":"Feng","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cgh.2018.04.031","article-title":"Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases.","volume":"16","author":"Aniwan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/gutjnl-2012-303285","article-title":"Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.","volume":"62","author":"Rungoe","year":"2013","journal-title":"Gut"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2011.06.032","article-title":"No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn\u2019s disease.","volume":"9","author":"Osterman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e0158926","DOI":"10.1371\/journal.pone.0158926","article-title":"Effect of the diagnosis of inflammatory bowel disease on risk-adjusted mortality in hospitalized patients with acute myocardial infarction, congestive heart failure and pneumonia.","volume":"11","author":"Ehrenpreis","year":"2016","journal-title":"PLoS One"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e29822","DOI":"10.1097\/MD.0000000000029822","article-title":"Acute pancreatitis as a rare adverse event among cannabis users: a systematic review.","volume":"101","author":"Jaiswal","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"21501319221074421501319221074450","DOI":"10.1177\/21501319221074450","article-title":"Cerebral venous sinus thrombosis following COVID-19 vaccination: a systematic review.","volume":"13","author":"Jaiswal","year":"2022","journal-title":"J Prim Care Community Health"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1179546820955171179546820955179","DOI":"10.1177\/1179546820955179","article-title":"An investigation into the association between inflammatory bowel disease and cardiac arrhythmias: an examination of the United States National inpatient sample database.","volume":"14","author":"Mubasher","year":"2020","journal-title":"Clin Med Insights Cardiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/MIB.0000000000000899","article-title":"Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a nationwide inpatient database.","volume":"22","author":"Barnes","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/ibd\/izy354","article-title":"Risk of myocardial infarction in inflammatory bowel disease: a population-based national study.","volume":"25","author":"Panhwar","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ibd\/izaa156","article-title":"Disease activity in inflammatory bowel disease is associated with arterial vascular disease.","volume":"27","author":"Card","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"e56944","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study.","volume":"8","author":"Kristensen","year":"2013","journal-title":"PLoS One"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MCA.0000000000000899","article-title":"Major acute cardiovascular events in patients with inflammatory bowel disease.","volume":"32","author":"Gill","year":"2021","journal-title":"Coron Artery Dis"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cgh.2007.09.016","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.","volume":"6","author":"Bernstein","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.","volume":"106","author":"Yarur","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00384-014-1862-6","article-title":"Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study.","volume":"29","author":"Keller","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00384-015-2132-y","article-title":"Increased risk of stroke among patients with Crohn\u2019s disease: a population-based matched cohort study.","volume":"30","author":"Keller","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/apt.15446","article-title":"Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study.","volume":"50","author":"Choi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.crohns.2011.01.011","article-title":"Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients.","volume":"5","author":"Sridhar","year":"2011","journal-title":"J Crohns Colitis"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017.","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R39-20250504","first-page":"1","article-title":"Health care utilization among US adults with inflammatory bowel disease, 2015-2016.","author":"Terlizzi","year":"2021","journal-title":"Natl Health Stat Report"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged \u226518 years \u2013 United States, 2015.","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"100316","DOI":"10.1016\/j.ajpc.2022.100316","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease in US adults-A population-level analysis in the national health interview survey.","volume":"9","author":"Nasir","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease.","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.3748\/wjg.v12.i30.4807","article-title":"Etiopathogenesis of inflammatory bowel diseases.","volume":"12","author":"Danese","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"oeab029","DOI":"10.1093\/ehjopen\/oeab029","article-title":"Inflammatory bowel disease and cardiovascular diseases: a concise review.","volume":"2","author":"Wu","year":"2021","journal-title":"Eur Heart J Open"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/HJH.0b013e3283568abd","article-title":"Arterial stiffness is increased in patients with inflammatory bowel disease.","volume":"30","author":"Zanoli","year":"2012","journal-title":"J Hypertens"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2018.08.067","article-title":"Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease.","volume":"175","author":"Kinchen","year":"2018","journal-title":"Cell"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis.","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjmed.2021.02.029","article-title":"Premature atherosclerotic cardiovascular disease risk among patients with inflammatory bowel disease.","volume":"134","author":"Lee","year":"2021","journal-title":"Am J Med"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.jacc.2020.10.027","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week.","volume":"76","author":"Cainzos-Achirica","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R50-20250504","first-page":"e649","article-title":"Correction to: 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task force on clinical practice guidelines.","volume":"140","year":"2019","journal-title":"Circulation"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice.","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ibd.20266","article-title":"Receipt of preventive health services by IBD patients is significantly lower than by primary care patients.","volume":"14","author":"Selby","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1038\/ctg.2015.49","article-title":"Physical fitness in adolescence and subsequent inflammatory bowel disease risk.","volume":"6","author":"Melinder","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0031-1295687","article-title":"Inflammatory bowel disease in the obese patient.","volume":"24","author":"Boutros","year":"2011","journal-title":"Clin Colon Rectal Surg"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000320395","article-title":"Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD.","volume":"28","author":"Cosnes","year":"2010","journal-title":"Dig Dis"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/ibd.20884","article-title":"Effects of active and passive smoking on disease course of Crohn\u2019s disease and ulcerative colitis.","volume":"15","author":"van der Heide","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.","volume":"340","author":"Jorenby","year":"1999","journal-title":"N Engl J Med"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of gastroenterology.","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"e010942","DOI":"10.1161\/JAHA.118.010942","article-title":"Inflammation and aortic pulse wave velocity: a multicenter longitudinal study in patients with inflammatory bowel disease.","volume":"8","author":"Zanoli","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/00365521.2021.1955147","article-title":"First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study.","volume":"56","author":"Anisdahl","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ibd\/izaa305","article-title":"Salicylates ameliorate intestinal inflammation by activating macrophage AMPK.","volume":"27","author":"Banskota","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1381612825666190405141410","article-title":"JAK inhibition: the most promising agents in the IBD pipeline?.","volume":"25","author":"Fern\u00e1ndez-Clotet","year":"2019","journal-title":"Curr Pharm Des"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/art.24567","article-title":"The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo [published correction appears in Arthritis Rheum. 2012 May;64(5):1487].","volume":"60","author":"Kremer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacl.2017.06.012","article-title":"Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis.","volume":"11","author":"Wolk","year":"2017","journal-title":"J Clin Lipidol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis.","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:01:41Z","timestamp":1746327701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032775","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}